Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1989-12-27
pubmed:abstractText
The trans-activator (Tat) proteins of the related but distinct type 1 and type 2 human immunodeficiency viruses (HIV-1 and HIV-2) display incomplete functional reciprocity. One possible explanation of this observation, suggested by computer analysis of potential RNA secondary structures within the viral trans-activation response (TAR) elements, is that HIV-2 Tat requires the presentation of two viral RNA stem-loop sequences for full activity whereas HIV-1 Tat is maximally active upon presentation of a single stem-loop structure. Here, we demonstrate that the HIV-2 long terminal repeat indeed contains two functionally independent TAR elements. However, the second (3') TAR element of HIV-2 is significantly less active than the 5' TAR element and is functionally masked in the context of an intact HIV-2 long terminal repeat. Evidence is presented suggesting that the activities of these two HIV-2 TAR elements reflect, at least in part, their relative distances from the site of transcription initiation. Although the HIV-2 TAR element proximal to the viral mRNA cap site appears to be sufficient for effective trans activation by HIV-2 Tat in vitro, this functional redundancy may nevertheless serve to enhance HIV-2 replication in infected cells in vivo.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2420471, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2456874, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2470647, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2536828, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2545899, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2546679, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2784194, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2786147, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2828036, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2828663, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2841583, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2849115, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-2988790, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3007995, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3025743, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3031510, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3033826, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3039372, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3131682, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3277274, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3386755, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3387221, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3412474, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3417148, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3476953, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3490693, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3530501, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3638988, http://linkedlifedata.com/resource/pubmed/commentcorrection/2555537-3643816
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5006-12
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Functional analysis of the Tat trans activator of human immunodeficiency virus type 2.
pubmed:affiliation
Howard Hughes Medical Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
pubmed:publicationType
Journal Article